Publications

Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer

Download PDF
Resource: Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer

.

Related Articles

Microfluidic-based immunohistochemistry combined with next-generation sequencing on diagnostic tissue sections for detection of tumoral BRAF V600E mutation

Link

Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics

Link